ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma

References

• RouseJJacksonSPInterfaces between the detection, signaling, and repair of DNA damageScience2002297558154755112142523
   PubMed Web of Science ®Google Scholar
• BakkenistCJKastanMBDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature2003421692249950612556884
   PubMed Web of Science ®Google Scholar
• HauPMTsaoSWEpstein–Barr virus hijacks DNA damage response transducers to orchestrate its life cycleViruses2017911341
   PubMed Web of Science ®Google Scholar
• PoonRYDNA damage checkpoints in nasopharyngeal carcinomaOral Oncol201450533934424503238
   PubMed Web of Science ®Google Scholar
• ChoudhuriTVermaSCLanKMurakamiMRobertsonESThe ATM/ATR signaling effector Chk2 is targeted by Epstein–Barr virus nuclear antigen 3C to release the G2/M cell cycle blockJ Virol200781126718673017409144
   PubMed Web of Science ®Google Scholar
• NikitinPAYanCMForteEAn ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein–Barr virus transformation of primary human B cellsCell Host Microbe20108651052221147465
   PubMed Web of Science ®Google Scholar
• ChenWHTangLQGuoSSPrognostic value of plasma Epstein– Barr virus DNA for local and regionally advanced nasopharyngeal carcinoma treated with cisplatin-based concurrent chemoradiotherapy in intensity-modulated radiotherapy eraMedicine2016955e264226844482
   PubMed Web of Science ®Google Scholar
• ChenMYinLWuJImpact of plasma Epstein–Barr virus–DNA and tumor volume on prognosis of locally advanced nasopharyngeal carcinomaBiomed Res Int2015201515
   Web of Science ®Google Scholar
• WagnerJMKarnitzLMCisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survivalMol Pharmacol200976120821419403702
   PubMed Web of Science ®Google Scholar
• SrinivasUSDyczkowskiJBeißbarthT5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repairOncotarget2015614125741258625909291
   PubMedGoogle Scholar
• KwokMDaviesNAgathanggelouASynthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathwayLancet20153851S5826312880
   PubMedGoogle Scholar
• CarrollBLPulkoski-GrossMJHannunYAObeidLMCHK1 regulates NF-κB signaling upon DNA damage in p53-deficient cells and associated tumor-derived microvesiclesOncotarget2016714181591817026921248
   PubMedGoogle Scholar
• WangLMoselAJOakleyGGPengADeficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancerMol Cancer Ther201211112401240922973056
   PubMed Web of Science ®Google Scholar
• BartekJLukasJChk1 and Chk2 kinases in checkpoint control and cancerCancer Cell20033542142912781359
   PubMed Web of Science ®Google Scholar
• ChehabNHMalikzayAStavridiESHalazonetisTDPhosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damageProc Natl Acad Sci U S A19999624137771378210570149
   PubMed Web of Science ®Google Scholar
• ChehabNHMalikzayAAppelMHalazonetisTDChk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53Genes Dev200014327828810673500
   PubMed Web of Science ®Google Scholar
• LukasCFalckJBartkovaJBartekJLukasJDistinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damageNat Cell Biol20035325526012598907
   PubMed Web of Science ®Google Scholar
• KastanMBBartekJCell-cycle checkpoints and cancerNature2004432701531632315549093
   PubMed Web of Science ®Google Scholar
• CaporaliSLevatiLStaraceGAKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibitionMol Pharmacol200874117318318413665
   PubMed Web of Science ®Google Scholar
• DanielssonKNylanderESjöströmMEbrahimiMEpstein–Barr virus is not detected in mucosal lichen planusMed Oral Patol Oral Cir Bucal2018235e560e56330148472
   PubMed Web of Science ®Google Scholar
• GruhneBSompallaeRMasucciMGThree Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpointsOncogene200928453997400819718051
   PubMed Web of Science ®Google Scholar
• GlaserRZhangHYYaoKTTwo epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein–Barr virus that were derived from nasopharyngeal carcinomasProc Natl Acad Sci U S A19898623952495282556716
   PubMed Web of Science ®Google Scholar
• BejaranoMTMasucciMGKleinGKleinET-cell-mediated inhibition of EBV-induced B-cell transformation: recognition of virus particlesInt J Cancer19884233593642843474
   PubMed Web of Science ®Google Scholar
• CicciaAElledgeSJThe DNA damage response: making it safe to play with knivesMol Cell201040217920420965415
   PubMed Web of Science ®Google Scholar
• ZengQWangZLiuCKnockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cellsMol Cell Biochem20164181–213714627334757
   PubMed Web of Science ®Google Scholar
• vera-SempereFJBurgosJSBotellaMSCordobaJGobernadoMImmunohistochemical expression of Epstein–Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patientsEur J Cancer B Oral Oncol199632B31631688762873
   PubMed Web of Science ®Google Scholar
• GulleyMLTangWLaboratory assays for Epstein–Barr virus-related diseaseJ Mol Diagn200810427929218556771
   PubMed Web of Science ®Google Scholar
• ChaHLoweJMLiHWip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage responseCancer Res201070104112412220460517
   PubMed Web of Science ®Google Scholar
• BonnerWMRedonCEDickeyJSγH2AX and cancerNat Rev Cancer200881295796719005492
   PubMed Web of Science ®Google Scholar
• FangCYLeeCHWuCCRecurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cellsInt J Cancer200912492016202519132751
   PubMed Web of Science ®Google Scholar
• HauPMDengWJiaLRole of ATM in the formation of the replication compartment during lytic replication of Epstein–Barr virus in nasopharyngeal epithelial cellsJ Virol201589165266825355892
   PubMed Web of Science ®Google Scholar
• ChoudhuriTVermaSCLanKMurakamiMRobertsonESThe ATM/ATR signaling effector Chk2 is targeted by Epstein–Barr virus nuclear antigen 3C to release the G2/M cell cycle blockJ Virol200781126718673017409144
   PubMed Web of Science ®Google Scholar
• SmithJThoLMXuNGillespieDAThe ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancerAdv Cancer Res20101087311221034966
   PubMed Web of Science ®Google Scholar
• MordasiniVUedaSAslandogmusRActivation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cellsOncotarget201686461
   Google Scholar
• HafezAYMessingerJEMcfaddenKLimited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalizationOncogenesis201766e34928604764
   PubMedGoogle Scholar
• BurrowsAEElledgeSJHow ATR turns on: TopBP1 goes on ATRIP with ATRGenes Dev200822111416142118519633
   PubMed Web of Science ®Google Scholar
• ToledoLIAltmeyerMRaskMBATR prohibits replication catastrophe by preventing global exhaustion of RPACell201315551088110324267891
   PubMed Web of Science ®Google Scholar
• AnanthaRWVassinVMBorowiecJASequential and synergistic modification of human RPA stimulates chromosomal DNA repairJ Biol Chem200728249359103592317928296
   PubMed Web of Science ®Google Scholar
• KogantiSHui-YuenJMcallisterSSTAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferationProc Natl Acad Sci U S A2014111134946495124639502
   PubMed Web of Science ®Google Scholar
• AdamsenBLKravikKLde AngelisPMDNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 statusInt J Oncol201139367368221674128
   PubMed Web of Science ®Google Scholar
• RezaeeMSancheLHuntingDJCisplatin enhances the formation of DNA single- and double-strand breaks by hydrated electrons and hydroxyl radicalsRadiat Res2013179332333123368416
   PubMed Web of Science ®Google Scholar
• JordanPCarmo-FonsecaMMolecular mechanisms involved in cisplatin cytotoxicityCell Mol Life Sci2000578–91229123511028915
   PubMed Web of Science ®Google Scholar
• KidiyoorGRKumarAFoianiMATR-mediated regulation of nuclear and cellular plasticityDNA Repair (Amst)20164414315027283761
   PubMed Web of Science ®Google Scholar
• MeiYPZhouJMWangYSilencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cellsCell Cycle20076111379138517507800
   PubMed Web of Science ®Google Scholar
• TibbettsRSBrumbaughKMWilliamsJMA role for ATR in the DNA damage-induced phosphorylation of p53Genes Dev19991321521579925639
   PubMed Web of Science ®Google Scholar
• RohalyGChemnitzJDehdeSA novel human p53 isoform is an essential element of the ATR-intra-S phase checkpointCell20051221213216009130
   PubMed Web of Science ®Google Scholar
• WangGBhoopalanVWangDWangLXuXThe effect of caffeine on cisplatin-induced apoptosis of lung cancer cellsExp Hematol Oncol20154525937999
   PubMedGoogle Scholar
• RosellRLordRVTaronMReguartNDNA repair and cisplatin resistance in non-small-cell lung cancerLung Cancer200238321722712445742
   PubMed Web of Science ®Google Scholar
• CimprichKACortezDATR: an essential regulator of genome integrityNat Rev Mol Cell Biol20089861662718594563
   PubMed Web of Science ®Google Scholar
• MaréchalAZouLDNA damage sensing by the ATM and ATR kinasesCold Spring Harb Perspect Biol201359a01271624003211
   PubMed Web of Science ®Google Scholar
• BuissonRNirajJRodrigueACoupling of homologous recombination and the checkpoint by ATRMol Cell201765233634628089683
   PubMed Web of Science ®Google Scholar
• QiuZOleinickNLZhangJATR/CHK1 inhibitors and cancer therapyRadiother Oncol2018126345046429054375
   PubMed Web of Science ®Google Scholar
• SørensenCSHansenLTDziegielewskiJThe cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repairNat Cell Biol20057219520115665856
   PubMed Web of Science ®Google Scholar
• WangXKennedyRDRayKStuckertPEllenbergerTD’AndreaADChk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathwayMol Cell Biol20072783098310817296736
   PubMed Web of Science ®Google Scholar
• ZhiGWilsonJBChenXFanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for Fanconi anemia pathway function and BRCA2 interactionCancer Res200969228775878319861535
   PubMed Web of Science ®Google Scholar
• MaackeHJostKOpitzSDNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinomaOncogene200019232791279510851081
   PubMed Web of Science ®Google Scholar
• NakanokoTSaekiHMoritaMRad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagusAnn Surg Oncol201421259760424065387
   PubMed Web of Science ®Google Scholar
• YazinskiSAComaillsVBuissonRATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cellsGenes Dev201731331833228242626
   PubMed Web of Science ®Google Scholar
• PeaslandAWangLZRowlingEIdentification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell linesBr J Cancer2011105337238121730979
   PubMed Web of Science ®Google Scholar
• BertrandPSaintignyYLopezBSp53’s double life: transactivation-independent repression of homologous recombinationTrends Genet200420623524315145576
   PubMed Web of Science ®Google Scholar
• RestleAJanzCWiesmüllerLDifferences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombinationOncogene200524274380438715806145
   PubMed Web of Science ®Google Scholar
• Arias-LopezCLazaro-TruebaIKerrPp53 modulates homologous recombination by transcriptional regulation of the RAD51 geneEMBO Rep20067221922416322760
   PubMed Web of Science ®Google Scholar